Lopinavir CAS 192725-17-0 API Ihe mgbochi mgbochi nje HIV COVID-19 dị ọcha
Onye nrụpụta nwere ịdị ọcha dị elu yana ịdị mma kwụsie ike
Aha Chemical: Lopinavir
OZI: 192725-17-0
Peptidomimetic HIV-1 Protease Inhibitor nke nwere ike dị ukwuu
Ngwaahịa nyocha metụtara COVID-19
API Ogo dị elu, mmepụta azụmahịa
Aha Chemical | Lopinavir |
Ụdị okwu | LPV;ABT-378;Kaletra |
Nọmba CAS | 192725-17-0 |
Nọmba CAT | RF-API73 |
Ọnọdụ Ahịa | Na Akụrụngwa, Mpụta Ihe ruru narị narị kilograms |
Usoro ihe omimi | C37H48N4O5 |
Ibu molekụla | 628.81 |
Nchekwa ogologo oge | Chekwaa ogologo oge na 2-8 ℃ |
Ụdị | Ruifu Chemical |
Ihe | Nkọwapụta |
Ọdịdị | Ọcha ka Gbanyụọ-Ọcha ntụ ntụ |
Solubility | Soluble n'efu na methanol yana na Ethanol, Soluble na 2-Propanol |
njirimara IR | Ụdị mmịpụta infrared nke ihe nlele ule kwekọrọ na ọkọlọtọ nrụtụ aka dị iche iche |
njirimara HPLC | Oge njide nke nlele ule dabara na nke ọkọlọtọ ntụaka |
Ọdịnaya mmiri (nke KF) | ≤4.0% |
Ntụgharị ngwa anya akọwapụtara | -22.0° ruo -26.0° |
Ihe fọdụrụ na mgbanye | ≤0.20% |
Ọla dị arọ | ≤20ppm |
Ebe Na-agbaze | 124.0 ruo 127.0 ℃ |
Sulfated Ash | ≤0.20% |
Ihe mgbaze fọdụrụ (Ethanol) | ≤0.50% |
Ihe ndị emetụtara | (HPLC, Mpaghara%) |
adịghị ọcha 1 | |
adịghị ọcha B (RRT=0.07) | ≤0.20% |
adịghị ọcha I (RRT=1.10) | ≤0.20% |
Ọdịghị ọcha ọ bụla ọzọ | ≤0.10% |
adịghị ọcha 2 | Ọdịghị ọcha nke onye ọ bụla ọzọ ≤0.10% |
Mgbakọta adịghị ọcha sitere na Usoro 1 na 2 | ≤0.70% |
Mgbakọta adịghị ọcha | ≤1.0% |
Nyocha (nke HPLC) | 98.0% ~ 102.0% |
Nlele ọkọlọtọ | Standardkpụrụ ụlọ ọrụ |
Ojiji | Nhọrọ Peptidomimetic HIV-1 Protease Inhibitor, Ngwaahịa nyocha metụtara COVID-19 |
ngwugwu: Kalama, Aluminom foil bag, kaadiboodu drum, 25kg / Drum, ma ọ bụ dị ka ndị ahịa chọrọ.
Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ọkụ, mmiri mmiri na ụmụ ahụhụ.
Lopinavir (ABT-378) bụ onye nwere ike nke ukwuu, onye na-egbochi peptidomimetic protease nke nje HIV-1, yana Kis nke 1.3 ruo 3.6 pM maka ụdị anụ ọhịa na nje nje HIV.Lopinavir na-eme ihe site na ijide nje HIV-1 tozuru okè si otú a na-egbochi nje ya.Lopinavir bụkwa ihe mgbochi SARS-CoV 3CLpro nwere IC50 nke 14.2 μM.Lopinavir bụ ọgwụ antiretroviral nke klas protease inhibitor.Mgbochi nke nje HIV-1 protease na-egbochi nkwụsị nke polyprotein precursor nke viral ma na-ebute ntọhapụ nke ndị na-eto eto, ndị na-adịghị efe efe.Akụkụ nke ọgwụgwọ ngwakọta iji gwọọ HIV/AIDS.Lopinavir, onye na-egbochi nje protease nke isii na klaasị "navir", ka ewepụtara ya na ritonavir, onye ọzọ na-egbochi nje nje HIV na-ere ahịa (Abbott, 1996);ewebata usoro izizi a dị ka Kaletra maka iji ya na nucleoside ma ọ bụ ndị na-abụghị nucleoside reverse transcriptase inhibitors maka ọgwụgwọ AIDS na ndị okenye na ụmụaka.Lopinavir bụ ngwakọta peptidomimetic nke nwere isi nhazi ya na nke ritonavir, bụ nke ndị otu ọnụ, ọkachasị valine emezigharịrị, webatara site na usoro njikọta peptide.Lopinavir bụ onye na-egbochi nje HIV-I protease nke na-egosipụta ikike dị elu megide mmụgharị na-eguzogide ritonavir.N'ime ụdị anụmanụ dị iche iche, ọmụmụ ọgwụ pharmacokinetic na otu lopinavirlritonavir gosipụtara na njirimara dị ala nke lopinavir dị mma nke ukwuu n'ihu ritonavir, n'ihe gbasara Cmax na oge ọrụ.